One challenge in biopharmaceutical development is the potential for low-level host cell proteins (HCPs) to remain in the final product, introducing a threat to product safety and efficacy. Monitoring of HCP levels is traditionally performed through enzyme-linked immunosorbent assay (ELISA), but this method lacks the specificity and coverage to identify and quantify individual HCPs. LC/MS technologies can overcome many challenges for HCP analysis, but better separation of peptides and broad dynamic range of the LC/MS system is important for this application. This study demonstrates an HCP analysis workflow including platforms and techniques for automated sample preparation, analysis, and data processing.
Please check the highlighted fields and try again.
Please enter your first and last name.
Please enter the name of the company or institution you work at.
Please enter your mailing address.
Please enter the e-mail address you would like to be contacted at.
Please enter the phone number you would like to be contacted at.